Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Tompkins Financial
TMP
$1.41B
| $2.26M | ﹤0.01% |
29,788
+15,751
| +112% | +$1.27M |
|
2227
Century Casinos
CNTY
$34.6M
| $2.25M | ﹤0.01% |
302,315
-123,472
| -29% | -$1.06M |
|
2228
The Bancorp
TBBK
$2.71B
| $2.25M | ﹤0.01% |
208,336
-419,808
| -67% | -$4.48M |
|
|
CMD
2229
DELISTED
Cantel Medical Corporation
CMD
| $2.25M | ﹤0.01% |
20,194
-8,442
| -29% | -$946K |
|
2230
Unitil
UTL
$974M
| $2.25M | ﹤0.01% |
48,370
+14,442
| +43% | +$634K |
|
|
AT
2231
DELISTED
Atlantic Power Corporation
AT
| $2.24M | ﹤0.01% |
1,065,881
+31,822
| +3% | +$68K |
|
2232
Snap-on
SNA
$20.5B
| $2.23M | ﹤0.01% |
15,111
+7,601
| +101% | +$1.25M |
|
|
CIVI
2233
DELISTED
Civitas Solutions, Inc.
CIVI
| $2.23M | ﹤0.01% |
144,715
+60,015
| +71% | +$913K |
|
2234
Henry Schein
HSIC
$10.1B
| $2.22M | ﹤0.01% |
42,180
+15,915
| +61% | +$882K |
|
|
EIGI
2235
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $2.22M | ﹤0.01% |
299,983
-37,656
| -11% | -$299K |
|
|
ARA
2236
DELISTED
American Renal Associates Holdings, Inc
ARA
| $2.22M | ﹤0.01% |
117,623
-75,043
| -39% | -$1.48M |
|
|
ALDR
2237
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.22M | ﹤0.01% |
174,555
-29,868
| -15% | -$432K |
|
2238
CALL
Exelixis
EXEL
$13.7B
| $2.21M | ﹤0.01% |
+100,000
| New | +$2.76M |
|
|
MRNS
2239
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.21M | ﹤0.01% |
144,785
-84,120
| -37% | -$2M |
|
2240
CALL
Kimberly-Clark
KMB
$36.6B
| $2.2M | ﹤0.01% |
+20,000
| New | +$2.28M |
|
|
PZN
2241
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $2.2M | ﹤0.01% |
197,848
+34,855
| +21% | +$395K |
|
2242
Dorman Products
DORM
$3.8B
| $2.19M | ﹤0.01% |
33,147
-70,702
| -68% | -$5.04M |
|
2243
Hackett Group
HCKT
$278M
| $2.18M | ﹤0.01% |
135,750
+11,965
| +10% | +$200K |
|
|
BNCL
2244
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $2.17M | ﹤0.01% |
139,822
-261,798
| -65% | -$4.17M |
|
|
KALV
2245
DELISTED
KalVista Pharmaceuticals
KALV
| $2.17M | ﹤0.01% |
229,248
-7,336
| -3% | -$76.8K |
|
|
TWNK
2246
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $2.17M | ﹤0.01% |
+146,825
| New | +$2.06M |
|
|
ONCT
2247
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $2.17M | ﹤0.01% |
871
+450
| +107% | +$1M |
|
2248
Anika Therapeutics
ANIK
$279M
| $2.16M | ﹤0.01% |
43,415
+39,554
| +1,024% | +$2.23M |
|
2249
Hyster-Yale Materials Handling
HY
$619M
| $2.16M | ﹤0.01% |
+30,856
| New | +$2.44M |
|
2250
AMC Entertainment Holdings
AMC
$2.41B
| $2.16M | ﹤0.01% |
+15,347
| New | +$2.18M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $2.48B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.